Seven independent prognostic factors for cancer‐specific survival of HER2‐positive breast cancer with bone metastases were identified: age, brain metastases, liver metastases, lung metastases, PR status, surgery, and chemotherapy. This evidence concerns the gene ERBB2 and cancer.